4D Pharma PLC (LBPS) Stock Income Statement
NASDAQ:LBPS - Nasdaq - US35085K1097 - ADR
| 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | 2018 (2018-12-31) | 2017 (2017-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 520.00K | 530.00K | 210.00K | 0.00 | 0.00 | |||
| Minority Interest Expense | N/A | N/A | N/A | 0.00 | 184.00K | |||
| Operating Expenses | 27.04M | 31.07M | 30.85M | 29.12M | 20.36M | |||
| Research and Development | 14.60M | 16.46M | 20.41M | 19.30M | 10.59M | |||
| Selling, General, and Administrative Expenses | 11.51M | 13.45M | 9.20M | 8.62M | 8.79M | |||
| Operating Income | -26.52M | -30.54M | -30.64M | -29.12M | -20.36M | |||
| Interest Income/Expense | 280.00K | 190.00K | -1.13M | 1.03M | 49.00K | |||
| Other Income/Expense | 13.18M | N/A | -330.00K | -350.00K | -121.00K | |||
| Non Recurring Items | -44.40M | 0.00 | 2.68M | -1.00K | -3.55M | |||
| Income Before Taxes | -57.47M | -30.35M | -29.43M | -28.44M | -23.99M | |||
| Income Tax | -3.50M | -4.38M | -5.36M | -4.75M | -3.54M | |||
| Net Income | -53.96M | -25.96M | -24.07M | -23.69M | -20.45M | |||
| EBITDA | -25.54M | -29.34M | -29.36M | -27.91M | -19.38M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.55 | -1.82 | -2.94 | -2.89 | -2.51 | |||
| Statistics | ||||||||
| Profit Margin | -10376.92% | -4898.11% | -11461.90% | N/A | N/A | |||
| Operating Profit Margin | -5100.00% | -5762.26% | -14590.48% | N/A | N/A | |||
All data in GBP